This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 52/1/123    most recent HYPERTENSIONAHA.107.099432v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Westhoff, J. H. Articles by Melk, A. Search for Related Content PubMed PubMed Citation Articles by Westhoff, J. H. Articles by Melk, A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB HYDRALAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM RESERPINE SPIRONOLACTONE Related Collections Other myocardial biology Cardiovascular Pharmacology Animal models of human disease Other hypertension Other Vascular biology Related Article

(Hypertension. 2008;52:123.)
© 2008 American Heart Association, Inc.

Original Articles

Hypertension Induces Somatic Cellular Senescence in Rats and Humans by Induction of Cell Cycle Inhibitor p16^INK4a

Jens H. Westhoff; Karl F. Hilgers; Mario P. Steinbach; Andrea Hartner; Bernd Klanke; Kerstin Amann; Anette Melk

From the Division of Pediatric Nephrology (J.H.W., M.P.S., A.M.), University Children’s Hospital, Heidelberg, Germany; and the Departments of Nephrology and Hypertension (K.F.H., A.H., B.K.) and Pathology (K.A.), University of Erlangen-Nuremberg, Erlangen, Germany.

Correspondence to Anette Melk, Children’s Hospital, Medical School Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. E-mail melk.anette{at}mh-hannover.de

There is increasing evidence for a role of somatic cellular senescence in physiological aging but also in injury and disease. Cell cycle inhibitor p16^INK4a is the key mediator for stress and aberrant signaling induced senescence. Here we report that elevated blood pressure markedly induced p16^INK4a expression in rat kidneys and hearts, as well as in human kidneys. In kidneys from deoxycorticosterone acetate-salt–treated rats, p16^INK4a induction was found in tubular, glomerular, interstitial, and vascular cells and correlated with the typical histopathologic features of hypertensive target organ damage. p16^INK4a expression also correlated with phospho-p38, a positive upstream regulator of p16^INK4a expression. In left ventricles, increased p16^INK4a expression was found in myocardium and cardiac arteries. Antihypertensive medication consistent of hydrochlorothiazide, hydralazine, and reserpine ameliorated the histopathologic changes and attenuated p16^INK4a expression in kidneys of deoxycorticosterone acetate-salt–treated rats. Nonantihypertensive administration of spironolactone also reduced kidney damage and p16^INK4a expression. p16^INK4a induction was further observed in kidneys from hypertensive transgenic rats heterozygous for the mouse Ren-2 gene and was prevented by the angiotensin II type 1 receptor blocker losartan. In human kidney biopsies showing hypertensive nephrosclerosis, increased p16^INK4a expression was found compared with age-matched normotensive control subjects. Thus, hypertension induces cellular senescence via p16^INK4a, possibly through p38, thereby contributing to hypertensive target organ damage. This detrimental effect can be overcome by different therapeutic drug strategies.

Key Words: target organ damage • kidney • heart • senescence • p16^INK4a expression • cell cycle inhibitor

Related Article:

Treatment-Sensitive Premature Renal and Heart Senescence in Hypertension

Martin W. Bergmann, Laura Zelarayan, and Christina Gehrke
Hypertension 2008 52: 61-62. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				S. Anderson, J. B. Halter, W. R. Hazzard, J. Himmelfarb, F. M. Horne, G. A. Kaysen, J. W. Kusek, S. G. Nayfield, K. Schmader, Y. Tian, et al. Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1199 - 1209. [Abstract] [Full Text] [PDF]

				J. F. E. Mann What's new in hypertension 2008? Nephrol. Dial. Transplant., January 1, 2009; 24(1): 38 - 42. [Full Text] [PDF]

				M. W. Bergmann, L. Zelarayan, and C. Gehrke Treatment-Sensitive Premature Renal and Heart Senescence in Hypertension Hypertension, July 1, 2008; 52(1): 61 - 62. [Full Text] [PDF]